OTX015, a BET-bromodomain (BET-BRD) inhibitor, potentiates the in vitro effects of chemotherapy drugs and targeted agents in human leukemic cell lines

被引：2
|
作者：
Astorgues-Xerri, L. [1 ]
Canet-Jourdan, C. [1 ]
Bekradda, M. [1 ]
Cvitkovic, E. [2 ]
Herait, P. [2 ]
Raymond, E. [3 ]
Riveiro, M. [1 ]
机构：
[1] Oncol Therapeut Dev, Clichy, France
[2] Oncoethix SA, Lausanne, Switzerland
[3] CHU Vaudois, Dept Med Oncol, Lausanne, Switzerland
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70693-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
567
引用
收藏
页码：183 / 183
页数：1
相关论文
共 27 条
  • [1] OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, is a promising anticancer agent for human glioblastoma
    Ouafik, L.
    Berenguer, C.
    Cayol, M.
    Astorgues-Xerri, L.
    Bekradda, M.
    Odore, E.
    Rezai, K.
    Riveiro, M. E.
    Cvitkovic, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 153 - 153
  • [2] In vitro evaluation of OTX015, a novel pan-BET-bromodomain (BET-BRD) inhibitor, as single agent and in combination with standard chemotherapy drugs in human leukemic cell lines
    Astorgues-Xerri, Lucile
    Vazquez, Ramiro
    Bekradda, Mohamed
    Cvitkovic, Esteban
    Herait, Patrice
    Raymond, Eric
    Riveiro, Mara E.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [3] OTX015, a novel BET-bromodomain (BET-BRD) inhibitor, displays antitumoral effects in orthotopic and heterotopic models of human glioblastoma
    Astorgues-xerri, Lucile
    Berenger, Caroline
    Cayol, Mylene
    Bekradda, Mohamed
    Odore, Elodie
    Rezai, Keyvan
    Cvitkovic, Esteban
    Riveiro, Maria E.
    Ouafik, L'Houcine
    [J]. CANCER RESEARCH, 2015, 75
  • [4] Preclinical Evaluation of the BET-Bromodomain (BET-BRD) Inhibitor OTX015 in Leukemia Cell Lines Harboring the JAK2 V617F Mutation
    Riveiro, Maria Eugenia
    Astorgues-Xerri, Lucile
    Canet-jourdan, Charlotte
    Bekradda, Mohamed
    Cvitkovic, Esteban
    Herait, Patrice
    Raymond, Eric
    [J]. BLOOD, 2014, 124 (21)
  • [5] The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple Myeloma
    Gu, Jie
    Song, Sha
    Han, Huiying
    Xu, Hongxia
    Fan, Gao
    Qian, Chen'ao
    Qiu, Yingchun
    Zhou, Wenqi
    Zhuang, Wenzhuo
    Li, Bingzong
    [J]. MOLECULAR PHARMACEUTICS, 2018, 15 (11) : 5387 - 5396
  • [6] Preclinical evaluation of OTX015, a novel BET-BRD inhibitor, on small cell lung cancer (SCLC) cell lines
    Ijaz, N.
    Astorgues-Xerri, L.
    Odore, E.
    Bekradda, M.
    Cvitkovic, E.
    Noel, K.
    Raymond, E.
    Riveiro, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 183 - 183
  • [7] A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Non-Leukemic Hematologic Malignancies
    Thieblemont, Catherine
    Stathis, Anastasios
    Inghirami, Giorgio
    Karlin, Lionel
    Morschhauser, Franck
    Gleeson, Mary
    Broussais, Florence
    Amorim, Sandy
    Salles, Gilles
    Facon, Thierry
    Cunningham, David
    Vey, Norbert
    Bourdel, Fabrice
    Herait, Patrice
    Zucca, Emanuele
    [J]. BLOOD, 2014, 124 (21)
  • [8] The BET-Bromodomain Inhibitor OTX015 Is Active As a Single Agent and in Combination with Other Targeted Drugs in Preclinical Models of Mantle Cell Lymphoma
    Bernasconi, Elena
    Tarantelli, Chiara
    Gaudio, Eugenio
    Kwee, Ivo
    Rinaldi, Andrea
    Cascione, Luciano
    Stathis, Anastasios
    Riveiro, Maria Eugenia
    Zucca, Emanuele
    Bertoni, Francesco
    [J]. BLOOD, 2014, 124 (21)
  • [9] A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Advanced Acute Leukemia
    Dombret, Herve
    Preudhomme, Claude
    Berthon, Celine
    Raffoux, Emmanuel
    Thomas, Xavier
    Vey, Norbert
    Gomez-Roca, Carlos
    Ethell, Mark
    Yee, Karen
    Bourdel, Fabrice
    Herait, Patrice
    Michallet, Mauricette
    Recher, Christian
    Roumier, Christophe
    Quesnel, Bruno
    [J]. BLOOD, 2014, 124 (21)
  • [10] Cellular pharmacokinetics and molecular pharmacodynamics studies of the BRD-BET inhibitor OTX015 in sensitive and resistant leukemic cell lines
    Odore, E.
    Astorgues-Xerri, L.
    Bekradda, M.
    Cvitkovic, E.
    Herait, P.
    Lokiec, F.
    Rezai, K.
    Riveiro, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 189 - 189
123